Daniel Schimmel
Interventional Cardiology · Chicago, ILNPI 1093974693
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (31.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Penumbra, Inc. at 26.5% of the total. Among interventional cardiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $340.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$21K
- Inari Medical, Inc.$17K
- Boston Scientific$11K
- Medtronic$10K
- Stryker$9K
- Inquis Medical, Inc.$6K
- plus $5K from 21 others
Across 71 payments — averaging $1992.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$68K
- Inari Medical, Inc.$37K
- EKOS Corporation$15K
- Daiichi Sankyo Inc.$11K
- Boston Scientific$10K
- Shockwave Medical, Inc$2K
What the payments were for
- Consulting fees$24,47531%
- Speaking & faculty fees$23,00029%
- Travel & lodging$20,62126%
- Food & beverage$10,95014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 44 | $20,959 |
| Inari Medical, Inc. | 33 | $17,311 |
| Boston Scientific | 42 | $10,956 |
| Medtronic(2 entities) | 16 | $9,614 |
| Stryker | 9 | $8,916 |
| Inquis Medical, Inc. | 5 | $6,269 |
| Abiomed | 17 | $1,736 |
| Edwards Lifesciences | 13 | $734 |
| Abbott | 7 | $450 |
| Cardiovascular Systems Inc. | 4 | $324 |
| Siemens Medical Solutions USA, Inc. | 2 | $289 |
| Cardiva Medical, Inc. | 4 | $270 |
| Asahi Intecc USA, Inc. | 3 | $194 |
| Biosense Webster, Inc. | 3 | $169 |
| Teleflex LLC | 2 | $154 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $133 |
| Atricure, Inc. | 2 | $105 |
| W. L. Gore & Associates, Inc. | 4 | $102 |
| Angiodynamics, Inc. | 4 | $89 |
| Philips North America LLC | 3 | $69 |
| Lexicon Pharmaceuticals, Inc. | 2 | $48 |
| Biotronik Inc. | 1 | $36 |
| Cordis US CORP. | 2 | $31 |
| Biobeat USA Inc. | 1 | $26 |
| Heartflow, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| Sandoz | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$25,257
- FLOWTRIEVER CATHETER, S$25,025
- Indigo System$16,102
- General - CT_IC$6,250
- Aventus$6,188
- RUBY Coil$4,080
- GENERAL VASCULAR ACCESS$1,536
- Impella$1,257
- AVVIGO Guidance System$1,132
- GENERAL - THERAPIES$765
- STINGRAY$418
- Penumbra System$410
- FlowTriever$300
- CorPath Imaging System$289
- PASCAL$215
- ASAHI PTCA Guide Wire$151
- Coronary Orbital Atherectomy System$151
- NUVISION ICE CATHETER$140
- ClotTriever$138
- Orsiro Mission$134
How this compares
$79,046 in reported general payments places this provider in the 90th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $41,672 |
| XareltoRivaroxaban | 26 | $30,168 |
| Repatha SureclickEvolocumab | 21 | $19,336 |
| JardianceEmpagliflozin | 15 | $17,336 |
| Praluent PenAlirocumab | 11 | $10,175 |
| Ranolazine ErRanolazine | 13 | $3,456 |
| Ezetimibe | 110 | $3,218 |
| Metoprolol Succinate | 178 | $3,077 |
| Atorvastatin Calcium | 241 | $2,861 |
| ClopidogrelClopidogrel Bisulfate | 176 | $2,490 |
| Rosuvastatin Calcium | 98 | $1,273 |
| Carvedilol | 59 | $848 |
| Prasugrel Hcl | 14 | $781 |
| Amlodipine Besylate | 140 | $772 |
| Losartan Potassium | 61 | $660 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Chicago
- Atman ShahChicago$788K
- David StewartChicago$169K
- Hussam SuradiChicago$97K
- Anita AsgarChicago$85K
- Ranya SweisChicago$62K
- Charles DavidsonChicago$62K
- Fareed Moses ColladoChicago$42K
- James FlahertyChicago$38K
- Ashvarya ManglaChicago$36K
- Marysa LeyaChicago$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.